TRAWS PHARMA INC (TRAW) Institutional Shareholders
TRAWS PHARMA INC (TRAW) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $5.19M in TRAW holdings during the latest filing period.
Orbimed Advisors Llc is currently the largest disclosed institutional shareholder of TRAW tracked by InsiderSet, reporting ownership valued at approximately $1.01M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $589,597.4, representing an estimated loss of -41.89% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 89% of the total disclosed TRAW value among the investors covered in this analysis. Major shareholders include Orbimed Advisors Llc, Ally Bridge Group (Ny) Llc, Adage Capital Partners Gp, L.L.C., and several other long-term asset managers with concentrated positions in TRAWS PHARMA INC (TRAW).
This page ranks the largest institutional TRAW shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
34
Total Reported Value
$5.19M
Largest Holder
Orbimed Advisors Llc
Largest Position
$1.01M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Orbimed Advisors Llc | 0.02% | 1,203,260 | $1,014,709 | $589,597 | -$425,112 | -41.89% | |
| Ally Bridge Group (Ny) Llc | 0.85% | 786,236 | $663,033 | $385,256 | -$277,777 | -41.89% | |
| Adage Capital Partners Gp, L.L.C. | 0.00% | 730,000 | $615,609 | $357,700 | -$257,909 | -41.89% | |
| Adar1 Capital Management, Llc | 0.02% | 597,729 | $504,065 | $292,887 | -$211,178 | -41.89% | |
| Lynx1 Capital Management Lp | 0.05% | 559,470 | $471,801 | $274,140 | -$197,661 | -41.89% | |
| Ikarian Capital, Llc | 0.07% | 478,142 | $403,217 | $234,290 | -$168,927 | -41.89% | |
| Sphera Funds Management Ltd. | 0.05% | 398,486 | $336,043 | $195,258 | -$140,785 | -41.89% | |
| Vanguard Capital Management Llc | 0.00% | 330,049 | $278,231 | $161,724 | -$116,507 | -41.87% | |
| Jane Street Group, Llc | 0.00% | 216,006 | $182,158 | $105,843 | -$76,315 | -41.89% | |
| Alyeska Investment Group, L.P. | 0.00% | 164,376 | $138,618 | $80,544 | -$58,074 | -41.89% | |
| Boothbay Fund Management, Llc | 0.00% | 133,936 | $112,948 | $65,629 | -$47,319 | -41.89% | |
| Geode Capital Management, Llc | 0.00% | 111,365 | $93,915 | $54,569 | -$39,346 | -41.90% | |
| Hrt Financial Lp | 0.00% | 91,220 | $76,000 | $44,698 | -$31,302 | -41.19% | |
| Kynam Capital Management, Lp | 0.00% | 84,400 | $71,175 | $41,356 | -$29,819 | -41.90% | |
| Dauntless Investment Group, Llc | 0.12% | 80,574 | $67,948 | $39,481 | -$28,467 | -41.89% | |
| Vanguard Fiduciary Trust Co | 0.00% | 54,511 | $45,953 | $26,710 | -$19,243 | -41.87% | |
| Northern Trust Corp | 0.00% | 37,454 | $31,585 | $18,352 | -$13,233 | -41.90% | |
| State Street Corp | 0.00% | 25,802 | $21,759 | $12,643 | -$9,116 | -41.90% | |
| Xtx Topco Ltd | 0.00% | 18,092 | $15,257 | $8,865 | -$6,392 | -41.89% | |
| Sg Americas Securities, Llc | 0.00% | 14,524 | $12,000 | $7,117 | -$4,883 | -40.69% | |
| Virtu Financial Llc | 0.00% | 12,579 | $11,000 | $6,164 | -$4,836 | -43.97% | |
| Blackrock, Inc. | 0.00% | 9,941 | $8,383 | $4,871 | -$3,512 | -41.89% | |
| Tower Research Capital Llc (Trc) | 0.00% | 5,142 | $4,336 | $2,520 | -$1,816 | -41.89% | |
| Huntington National Bank | 0.00% | 4,676 | $3,943 | $2,291 | -$1,652 | -41.89% | |
| Ubs Group Ag | 0.00% | 3,451 | $2,909 | $1,691 | -$1,218 | -41.87% | |
| Barclays Plc | 0.00% | 1,947 | $1,642 | $954 | -$688 | -41.90% | |
| Sbi Securities Co., Ltd. | 0.00% | 1,721 | $1,451 | $843 | -$608 | -41.88% | |
| Federation Des Caisses Desjardins Du Quebec | 0.00% | 500 | $414 | $245 | -$169 | -40.82% | |
| Morgan Stanley | 0.00% | 468 | $395 | $229 | -$166 | -41.94% | |
| Vanguard Global Advisers, Llc | 0.00% | 262 | $221 | $128 | -$93 | -41.91% | |
| Cassaday & Co Wealth Management Llc | 0.00% | 6 | $6 | $3 | -$3 | -51.00% | |
| Harbour Investments, Inc. | 0.00% | 5 | $4 | $2 | -$2 | -38.75% | |
| Fmr Llc | 0.00% | 2 | $2 | $1 | -$1 | -51.00% | |
| Jones Financial Companies Lllp | 0.00% | 2 | $2 | $1 | -$1 | -51.00% |
Frequently asked questions about TRAW
Who owns the most TRAW stock?
The largest holders of TRAW are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TRAWS PHARMA INC (TRAW).
Is TRAW widely held by superinvestors?
Many widely followed stocks like TRAW appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TRAW is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.